Literature DB >> 16085416

Synthesis and structure-activity relationship of N-alkyl Gly-boro-Pro inhibitors of DPP4, FAP, and DPP7.

Yi Hu1, Lifu Ma, Min Wu, Melissa S Wong, Bei Li, Sergio Corral, Zhizhou Yu, Tyzoon Nomanbhoy, Senaiet Alemayehu, Stacy R Fuller, Jonathan S Rosenblum, Natasha Rozenkrants, Lauro C Minimo, William C Ripka, Anna K Szardenings, John W Kozarich, Kevin R Shreder.   

Abstract

The structure-activity relationship of various N-alkyl Gly-boro-Pro derivatives against three dipeptidyl peptidases (DPPs) was studied. In a series of N-cycloalkyl analogs, DPP4 and fibroblast activation protein-alpha (FAP) optimally preferred N-cycloheptyl whereas DPP7 tolerated even larger cycloalkyl rings. Gly alpha-carbon derivatization of N-cyclohexyl or N-(2-adamantyl) Gly-boro-Pro resulted in a significant decrease in potency against all the three DPPs.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16085416     DOI: 10.1016/j.bmcl.2005.06.075

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  6 in total

1.  Synthesis and activity of a potent, specific azabicyclo[3.3.0]-octane-based DPP II inhibitor.

Authors:  Olga Danilova; Bei Li; A Katrin Szardenings; Brigitte T Huber; Jonathan S Rosenblum
Journal:  Bioorg Med Chem Lett       Date:  2006-10-10       Impact factor: 2.823

2.  Selective Inhibitors of Fibroblast Activation Protein (FAP) with a (4-Quinolinoyl)-glycyl-2-cyanopyrrolidine Scaffold.

Authors:  Koen Jansen; Leen Heirbaut; Jonathan D Cheng; Jurgen Joossens; Oxana Ryabtsova; Paul Cos; Louis Maes; Anne-Marie Lambeir; Ingrid De Meester; Koen Augustyns; Pieter Van der Veken
Journal:  ACS Med Chem Lett       Date:  2013-03-18       Impact factor: 4.345

3.  Selective fluorescence probes for dipeptidyl peptidase activity-fibroblast activation protein and dipeptidyl peptidase IV.

Authors:  Koon Siew Lai; Nan-Hui Ho; Jonathan D Cheng; Ching-Hsuan Tung
Journal:  Bioconjug Chem       Date:  2007-05-10       Impact factor: 4.774

4.  Targeting fibroblast activation protein inhibits tumor stromagenesis and growth in mice.

Authors:  Angélica M Santos; Jason Jung; Nazneen Aziz; Joseph L Kissil; Ellen Puré
Journal:  J Clin Invest       Date:  2009-11-16       Impact factor: 14.808

5.  Imaging of Fibroblast Activation Protein in Cancer Xenografts Using Novel (4-Quinolinoyl)-glycyl-2-cyanopyrrolidine-Based Small Molecules.

Authors:  Stephanie L Slania; Deepankar Das; Ala Lisok; Yong Du; Zirui Jiang; Ronnie C Mease; Steven P Rowe; Sridhar Nimmagadda; Xing Yang; Martin G Pomper
Journal:  J Med Chem       Date:  2021-03-17       Impact factor: 8.039

6.  Evaluation of the radiolabeled boronic acid-based FAP inhibitor MIP-1232 for atherosclerotic plaque imaging.

Authors:  Romana Meletta; Adrienne Müller Herde; Aristeidis Chiotellis; Malsor Isa; Zoran Rancic; Nicole Borel; Simon M Ametamey; Stefanie D Krämer; Roger Schibli
Journal:  Molecules       Date:  2015-01-27       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.